Email Updates

You are here

Home

AVAC's Blog: P-Values

  • Golden Age or Fools Gold?

    Are we in the Golden Age of HIV prevention, as first heralded at the 2016 International AIDS Society conference? Listen to this short interview with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH, where he explains the recent progress and upcoming HIV prevention trials, and what it will take to “put out the fire.”

    September 13, 2017
    General
    AVAC

  • Informing the Research Enterprise: Webinar with Carl Dieffenbach on future priorities for HIV research networks

    We recently held a webinar with Dr. Carl Dieffenbach, the Director of the Division of AIDS (DAIDS) at the NIH’s National Institute of Allergy and Infectious Diseases, about the future of investments in the US National Institutes of Health’s (NIH) HIV clinical trial research networks in the US and internationally.

    September 6, 2017
    General
    AVAC

  • PrEP’s Entry into Kenya: Communities hold the key

    Kenyan civil society recently called a meeting with the leaders and implementers of oral pre-exposure prophylaxis (PrEP) activities in the country. The meeting’s purpose was to have a frank discussion about the role of community support in the national PrEP program, and touch on progress with HIV self-testing implementation.
    August 8, 2017
    PrEP
    Daisy Ouya

  • Announcing the Call for 2018 Advocacy Fellows

    AVAC is pleased to announce the call for applications for 2018 Advocacy Fellows. Consider applying to be an Advocacy Fellow and join the 56 Fellows and alumni of the program!

    August 3, 2017
    General
    AVAC

  • Raped at 11, Ntokozo is Finally Able to Tell Her Story, 13 Years Later

    Ntokozo Zakwe is a young woman from Hillcrest in KwaZulu Natal who was raped when she was only 11 years old. The man who raped her threatened her and said there would be consequences if she told anyone about it. Now, thirteen years later, she is ready to tell her story.

    July 31, 2017
    General
    Zizo Zikali

  • AVAC's Snapshot from IAS 2017

    Several members of AVAC are attending the International AIDS Society meeting in Paris this week. This update offers a selective, whirlwind tour of conference events.

    July 25, 2017
    General
    AVAC

  • Prevention on the “Slow Track”: What UNAIDS missed in its annual progress report

    Last year at the Durban AIDS Conference, many of us donned big round stickers that said “Code Red” for HIV prevention. If you’ve got yours, perhaps on a conference bag or t-shirt, you’ve got the main message we’d like to convey regarding the new UNAIDS report on the state of the HIV epidemic.

    July 21, 2017
    General
    AVAC

  • New Report: Investment trends for HIV prevention and cure R&D

    This year’s funding report shows that prevention funding continues to slowly decline overall. Over the same time, cure research got a big bump from global funders. A separate cure-focused brief, developed in partnership with the International AIDS Society, showed investment in cure research tripled since 2012.

    July 20, 2017
    HIV Vaccine, Male and Female Condoms, Cure, Microbicides, PrEP, Therapeutic Vaccines, Treatment, Voluntary Medical Male Circumcision
    AVAC

  • IAS 2017: A guide to navigating the conference on-site and online

    This post contains information on the upcoming IAS 2017 conference taking place July 23–26 in Paris. Read on for details on AVAC satellite sessions, data to watch for, a prevention roadmap and all the ways to follow next week’s developments from the City of Light!

    July 18, 2017
    General
    AVAC

  • What’s Up HIV: Supporting young journalists to report on the science and the human face of HIV

    AVAC has partnered with Community Media Trust since 2013 to produce the What’sUpHIV blog to report on HIV conferences in South Africa, but for the first time we provided scholarships to journalists whose sole mission at the conference was to write for the blog.

    July 17, 2017
    General
    AVAC

Pages

view more